Publication

학술지 개제논문

SCI 등재 학술지에 게재된 논문 (2016 ~ 2015)

254. Rhee H, Nahm JH, Kim H, Choi GH, Yoo JE, Lee HS, Koh MJ, Park YN: Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization. Mod Pathol 2016.
253. Park YY, Sohn BH, Johnson RL, Kang MH, Kim SB, Shim JJ, Mangala LS, Kim JH, Yoo JE, Rodriguez-Aguayo C, Pradeep S, Hwang JE, Jang HJ, Lee HS, Rupaimoole R, Lopez-Berestein G, Jeong W, Park IS, Park YN, Sood AK, Mills GB, Lee JS: Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma. Hepatology 2016, 63:159-172.
252. Nahm JH, Kim H, Lee H, Cho JY, Choi YR, Yoon YS, Han HS, Park YN: Transforming acidic coiled-coil-containing protein 3 (TACC3) overexpression in hepatocellular carcinomas is associated with "stemness" and epithelial-mesenchymal transition-related marker expression and a poor prognosis. Tumour Biol 2016, 37:393-403.
251. Na TY, Ka NL, Rhee H, Kyeong D, Kim MH, Seong JK, Park YN, Lee MO: Interaction of hepatitis B virus X protein with PARP1 results in inhibition of DNA repair in hepatocellular carcinoma. Oncogene 2016.
250. Lim SM, Yoo JE, Lim KH, Meng Tai DW, Cho BC, Park YN: Rare Incidence of ROS1 Rearrangement in Cholangiocarcinoma. Cancer Res Treat 2016.
249. Lee HW, Kang W, Kim BK, Kim SU, Park JY, Kim do Y, Ahn SH, Park YN, Han KH: Red cell volume distribution width-to-platelet ratio in assessment of liver fibrosis in patients with chronic hepatitis B. Liver Int 2016, 36:24-30.
248. Lee HW, Chon YE, Kim SU, Kim BK, Park JY, Kim DY, Ahn SH, Jung KS, Park YN, Han KH: Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response. Gut Liver 2016, 10:429-436.
247. Lee HG, Kim H, Son T, Jeong Y, Kim SU, Dong SM, Park YN, Lee JD, Lee JM, Park JH: Regulation of HK2 expression through alterations in CpG methylation of the HK2 promoter during progression of hepatocellular carcinoma. Oncotarget 2016.
246. Lanza E, Donadon M, Poretti D, Pedicini V, Tramarin M, Roncalli M, Rhee H, Park YN, Torzilli G: Transarterial Therapies for Hepatocellular Carcinoma. Liver Cancer 2016, 6:27-33.
245. Kwon T, Bak Y, Park YH, Jang GB, Nam JS, Yoo JE, Park YN, Bak IS, Kim JM, Yoon DY, Yu DY: Peroxiredoxin II Is Essential for Maintaining Stemness by Redox Regulation in Liver Cancer Cells. Stem Cells 2016, 34:1188-1197.
244. Koh J, Chung YE, Nahm JH, Kim HY, Kim KS, Park YN, Kim MJ, Choi JY: Intrahepatic mass-forming cholangiocarcinoma: prognostic value of preoperative gadoxetic acid-enhanced MRI. Eur Radiol 2016, 26:407-416.
243. Kim JW, Seong J, Park MS, Kim KS, Park YN, Han KH, Keum KC, Lee IJ: Radiological-pathological correlation study of hepatocellular carcinoma undergoing local chemoradiotherapy and surgery. J Gastroenterol Hepatol 2016.
242. Kim HJ, Park YE, Ki MS, Lee SJ, Beom SH, Han DH, Park YN, Park JY: Spontaneous rupture of hepatic metastasis from a thymoma: A case report. World J Gastroenterol 2016, 22:9860-9864.
241. Heo JY, Kim SU, Kim BK, Park JY, Kim do Y, Ahn SH, Park YN, Ahn SS, Han KH, Kim HS: Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus. Medicine (Baltimore) 2016, 95:e3328.
240. Han DH, Joo DJ, Kim MS, Choi GH, Choi JS, Park YN, Seong J, Han KH, Kim SI: Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis after Concurrent Chemoradiation Therapy. Yonsei Med J 2016, 57:1276-1281.
239. Park H, Lee H, Seo AN, Cho JY, Choi YR, Yoon YS, Han HS, Park YN, Kim H: SALL4 Expression in Hepatocellular Carcinomas Is Associated with EpCAM-Positivity and a Poor Prognosis. J Pathol Transl Med 2015, 49:373-381.
238. Ko SK, Kim J, Na DC, Park S, Park SH, Hyun JY, Baek KH, Kim ND, Kim NK, Park YN, Song K, Shin I: A small molecule inhibitor of ATPase activity of HSP70 induces apoptosis and has antitumor activities. Chem Biol 2015, 22:391-403.
237. Kim SB, Kim do K, Byun SJ, Park JH, Choi JY, Park YN, Kim do Y: Peliosis hepatis presenting with massive hepatomegaly in a patient with idiopathic thrombocytopenic purpura. Clin Mol Hepatol 2015, 21:387-392.
236. Kim MN, Kim SU, Kim BK, Park JY, Kim do Y, Ahn SH, Song KJ, Park YN, Han KH: Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography-defined subclinical cirrhosis. Hepatology 2015, 61:1851-1859.
235. Kim HM, Kim H, Park YN: Sarcomatoid cholangiocarcinoma with osteoclast-like giant cells associated with hepatolithiasis: A case report. Clin Mol Hepatol 2015, 21:309-313.
234. Kim H, Nahm JH, Park YN: Budd-Chiari syndrome with multiple large regenerative nodules. Clin Mol Hepatol 2015, 21:89-94.
233. Kim BY, Choi DW, Woo SR, Park ER, Lee JG, Kim SH, Koo I, Park SH, Han CJ, Kim SB, Yeom YI, Yang SJ, Yu A, Lee JW, Jang JJ, Cho MH, Jeon WK, Park YN, Suh KS, Lee KH: Recurrence-associated pathways in hepatitis B virus-positive hepatocellular carcinoma. BMC Genomics 2015, 16:279.
232. Jung IH, Choi JH, Chung YY, Lim GL, Park YN, Park SW: Predominant Activation of JAK/STAT3 Pathway by Interleukin-6 Is Implicated in Hepatocarcinogenesis. Neoplasia 2015, 17:586-597.
231. Choi GH, Kim GI, Yoo JE, Na DC, Han DH, Roh YH, Park YN, Choi JS: Increased Expression of Circulating Cancer Stem Cell Markers During the Perioperative Period Predicts Early Recurrence After Curative Resection of Hepatocellular Carcinoma. Ann Surg Oncol 2015, 22 Suppl 3:S1444-1452.
230. Cha J, Jeon TW, Lee CG, Oh ST, Yang HB, Choi KJ, Seo D, Yun I, Baik IH, Park KR, Park YN, Lee YH: Electro-hyperthermia inhibits glioma tumorigenicity through the induction of E2F1-mediated apoptosis. Int J Hyperthermia 2015, 31:784-792.
229. An C, Kim DW, Park YN, Chung YE, Rhee H, Kim MJ: Single Hepatocellular Carcinoma: Preoperative MR Imaging to Predict Early Recurrence after Curative Resection. Radiology 2015, 276:433-443.